Defining the Place of Emerging IgE-targeted Therapies in Team-based Management of Food Allergies
September 20, 2023
September 20, 2024
Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the Asthma and Allergy Foundation of America (AAFA) and Food Allergy Research & Education (FARE).
This activity is supported by an independent educational grant from Genentech, a member of the Roche Group.
Date of Release/Expiration
This activity was released on September 20, 2023 and is valid until September 20, 2024. Requests for credit must be made no later than September 20, 2024.
- Physicians - maximum of 0.5 AMA PRA Category 1 Credits™
The educational design of this activity addresses the needs of allergists/immunologists, pediatricians, and primary care clinicians (MDs/DOs/NPs/PAs).
The global occurrence of food allergies is increasing due to environmental, lifestyle, and nutritional factors. Food allergies pose heavy emotional, social, and financial impacts on those affected and their families; however, emerging treatments that target the underlying mechanisms of food allergies and common comorbidities are showing promise in clinical trials Increasingly, the onus is on front-line clinicians to counsel patients and families and work with allergists to help break down barriers to accessing appropriate care.
Join a panel of allergy and primary care clinicians to discuss the mechanisms of action and efficacy/safety profiles of emerging anti-immunoglobulin E (IgE) therapies for food allergies and where these agents may fit in the treatment algorithm. Expert panelists will, thus, share the implications and goals of different therapeutic approaches, review when and how to counsel patients as part of shared decision-making, and also identify the roles and responsibilities of each member of the care team involved in the management of food allergies and comorbidities.
After completing this activity, the participant should be better able to:
- Describe current evidence supporting the efficacy and safety of emerging biologics that target the underlying pathophysiology of food allergies and common comorbidities
- Summarize strategies to develop a multidisciplinary, patient-centered approach to the management of people with food allergies and other immunoglobulin E mediated comorbidities
Jennifer Dantzer, MD, MHS
Assistant Professor of Pediatrics
Pediatric Allergy, Immunology, and Rheumatology
Johns Hopkins School of Medicine
Robert A. Wood, MD
Professor of Pediatrics and International Health
Director, Eudowood Division of Pediatric Allergy, Immunology, and Rheumatology
Director, Pediatric Clinical Research Unit
Johns Hopkins University School of Medicine
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instruction for Participaton and Credit:
Estimated Time to Complete
This activity should take approximately 30 minutes to complete.
Instruction to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 75% on the post-test.
Course Viewing Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Faculty and Disclosure of Conflicts of Interest
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The PlatformQ Health Education, LLC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
For additional information about the accreditation of this activity, please visit https://partnersed.com.
For any technical issues or issues with your CME Certificate, please contact ImmunologyLive at 877-394-1306 or at [email protected].
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes..
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at [email protected]
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting [email protected] with the subject line “Data Request”